×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 11 Track 2B: Personalized Medicine: Gene Therapy
Session Chair(s)
Eileen Girten, MS
Director, Medical Writing
Pfizer Inc, United States
You will leave this session with a basic understanding of what gene therapy is, how gene therapy works, and the challenges associated with education and awareness in the gene therapy space.
Learning Objective : At the conclusion of this session, participants should be able to:- Differentiate between basic types of gene therapy
- Explain how gene therapy works using simple terms
- Describe the key challenges associated with educating audiences about gene therapy
- Identify key insights regarding the straightforward communication of complex science
Speaker(s)
AAV Gene Therapies for Rare Diseases
Kendra Bolt, PhD
Audentes Therapeutics, United States
Senior Manager of Scientific Communications
Have an account?